Previous close | 0.1181 |
Open | 0.1050 |
Bid | 0.1021 x 400 |
Ask | 0.1090 x 300 |
Day's range | 0.1000 - 0.1150 |
52-week range | 0.0900 - 0.8350 |
Volume | |
Avg. volume | 2,858,214 |
Market cap | 17.611M |
Beta (5Y monthly) | 1.30 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SAN DIEGO, May 14, 2024--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days.
SAN DIEGO, April 29, 2024--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call.
SAN DIEGO, March 20, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage: